We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Menthol Spray Boosts Detection Rate of Polyps

By HospiMedica International staff writers
Posted on 21 May 2014
Spraying the colon with L-menthol—an organic compound found in peppermint oil—improves adenoma detection rate during colonoscopy, according to a new study.

Researchers at the University of Western Ontario (UWO; London, Canada) conducted a randomized, placebo-controlled trial at Kyoto Prefectural University (Japan) involving 226 patients (118 study cohort, 108 controls). More...
An 8 mL volume of peppermint oil and 0.2 mL of polysorbate were gently mixed and dissolved in 500 mL of distilled water to manufacture L-menthol. The placebo used was water and dimethicone. All procedures were performed by one of three colonoscopists who had performed over 1,000 procedures.

In each case, the colonoscope was inserted as far as the cecum, and placebo or L-menthol was then directly and gently sprayed onto the cecum through the working channel of the endoscope. At that time, endoscopic evaluation of colon was initiated. The results showed that the adenoma detection rate was 42.6% among the placebo-treated patients and 60.2% in the menthol treated patients. In addition to increasing the detection rate, using the L-menthol spray also appeared to suppress gastric peristalsis, which can adversely impact colonoscopy.

The researchers suggest that the antiperistalsis effects of L-menthol are partly responsible for the improve polyp detection. In addition to the low-grade polyp detection, patients who were treated with L-menthol also had more high-grade or cancerous lesions observed during the colonoscopy. There were 13 precancerous or cancerous lesions found among the patients in which menthol was used, compared with 7 such lesions among the placebo-treated patients. The study was presented at Digestive Disease Week (DDW), held during May 2014 in Chicago (IL, USA).

"We were very happy to discover that the adenoma detection rate in the L-menthol group was significantly [greater] by almost 20%. In addition to increasing the detection rate, using the L-menthol spray also appears to suppress gastric peristalsis, which can adversely impact colonoscopy,” said lead author and study presenter Ken Inoue, MD, PhD. “30.9% of placebo patients were free of peristalsis, compared with 71.2% of those patients who underwent colonoscopy using the menthol spray.”

Peristalsis is a radial, symmetrical contraction and relaxation of muscles which propagates a wave motion in an anterograde fashion. The circular smooth muscles in the gastrointestinal (GI) tract contract in sequence to produce a peristaltic wave, followed by a contraction of longitudinal smooth muscles which pushes the digested food forward.

Related Links:

University of Western Ontario
Kyoto Prefectural University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.